Literature DB >> 31555833

[Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options].

D C Richter1, T Brenner2, A Brinkmann3, B Grabein4, M Hochreiter2, A Heininger5, D Störzinger6, J Briegel7, M Pletz8, M A Weigand2, C Lichtenstern2.   

Abstract

The increase in resistant pathogens has long been a global problem. Complicated life-threatening infections due to multidrug-resistant pathogens (MRD) meanwhile occur regularly in intensive care medicine. An important and also potentially modifiable factor of the rapid spread of resistance is the irrational use of broad spectrum antibiotics in human medicine. In addition to many other resistance mechanisms, beta-lactamases play an important role in Gram-negative pathogens. They are not uncommonly the leading reason of difficult to treat infections and the failure of known routinely used broad spectrum antibiotics, such as cephalosporins, (acylamino)penicillins and carbapenems. Strategies for containment of MRDs primaríly target the rational use of antibiotics. In this respect interdisciplinary treatment teams, e.g. antibiotic stewardship (ABS) and infectious diseases stewardship (IDS) play a major role.

Entities:  

Keywords:  Beta-lactamases; Carbapenem-resistant Enterobacteriaceae; Methicillin-resistant Staphylococcus aureus; Sepsis; Vancomycin-resistant Enterococci

Year:  2019        PMID: 31555833     DOI: 10.1007/s00101-019-00645-0

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  77 in total

1.  Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.

Authors:  Nicholas S Britt; Emily M Potter; Nimish Patel; Molly E Steed
Journal:  Clin Infect Dis       Date:  2015-06-10       Impact factor: 9.079

2.  Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1986-11       Impact factor: 5.226

Review 3.  Vancomycin-associated nephrotoxicity: A meta-analysis of administration by continuous versus intermittent infusion.

Authors:  Timothy Hanrahan; Tony Whitehouse; Jeffrey Lipman; Jason A Roberts
Journal:  Int J Antimicrob Agents       Date:  2015-06-07       Impact factor: 5.283

Review 4.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

5.  Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.

Authors:  Brandon P Mullins; C Joseph Kramer; Billie J Bartel; Jennifer S Catlin; Richard E Gilder
Journal:  Ann Pharmacother       Date:  2018-02-14       Impact factor: 3.154

Review 6.  Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review.

Authors:  Matthew E Falagas; Kyriakos K Trigkidis; Konstantinos Z Vardakas
Journal:  Int J Antimicrob Agents       Date:  2014-11-06       Impact factor: 5.283

Review 7.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  [Not Available].

Authors:  Christine Geffers; Friederike Maechler; Michael Behnke; Petra Gastmeier
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2016-03-07       Impact factor: 0.698

Review 9.  Antibiotic strategies in the era of multidrug resistance.

Authors:  George Karam; Jean Chastre; Mark H Wilcox; Jean-Louis Vincent
Journal:  Crit Care       Date:  2016-06-22       Impact factor: 9.097

10.  ESBL colonization and acquisition in a hospital population: The molecular epidemiology and transmission of resistance genes.

Authors:  Stefan Hagel; Oliwia Makarewicz; Anita Hartung; Daniel Weiß; Claudia Stein; Christian Brandt; Ulrike Schumacher; Ralf Ehricht; Vladimir Patchev; Mathias W Pletz
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

View more
  1 in total

1.  Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus.

Authors:  Zijing Ruan; Jiaqi Cui; Zhenqing He; Yuting Guo; Xu Jia; Xinhe Huang
Journal:  Infect Drug Resist       Date:  2020-08-13       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.